Certifications
Sector Experience
Experience
(2) Led and oversaw HEOR evidence generation projects requiring primary data collection (non-interventional studies);
(3) Represented Global Market Access function in the cross-function team in planning luspatercept launch for thalassemia and myeloproliferative neoplasm indications; and
(4) As a gate-keeper for all HEOR related data to be communicated to scientific communities.